Derby & Company’s Pfizer PFE Stock Holding History

Derby & Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$230K	Hold	5,349	–	–	0.05%	77
2021 Q2	$209K	Buy	+5,349	New	+$208K	0.04%	77

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Derby & Company's PFE Position: Q3 2021 in Review

Derby & Company held its Pfizer (PFE) position steady in Q3 2021 at 5,349 shares worth $230K. The position accounts for 0.05% of the portfolio, ranked #77.

Derby & Company first reported a position in PFE in Q2 2021 and has held it in 2 quarters since. 2,805 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

Derby & Company held 5,349 shares of Pfizer worth $230K as of Q3 2021.
Derby & Company left its Pfizer share count unchanged in Q3 2021.
Pfizer made up 0.05% of Derby & Company's portfolio in Q3 2021, its #77 holding.
Derby & Company first reported a position in Pfizer in Q2 2021 and has held it in 2 quarters since.
2,805 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Derby & Company's 13F filing for Q3 2021, filed 12 Nov 2021.